Novo vs. KBP: How a $1.3B deal turned into an international legal fight
american tariffs and US flag on yellow caution line i
Biotech

‘Let that one go’: Nkarta CEO urges US gov to drop China policies

Restrictions on Chinese science hurt the people that matter most—the patients—Nkarta CEO Paul Hastings told Fierce.
Gabrielle Masson Oct 16, 2025 2:00pm
Learn strategies to address PFAS challenges facing the medical device industry

Understanding the Impact of PFAS "Forever Chemicals" on Medical Devices

Oct 13, 2025 8:00am
kite

Kite puts $1.64B on the line for Pregene’s in vivo CAR-Ts

Oct 16, 2025 4:56pm
10102025

Neuroinflammation a Key Underlying Factor in Alzheimer’s Disease Risk

Oct 13, 2025 8:00am
An arrow incrementally going up stairs before pointing straight up Blue background

Praxis plots path to FDA after phase 3 wins in essential tremor

Oct 16, 2025 11:48am
The city of Marseille France as viewed through an aerial camera

French antibody biotech draws in $122M for push to clinic

Oct 16, 2025 11:19am
More News

Fierce Biotech Fundraising Tracker: Peptilogics, Tubulis & more

Oct 16, 2025 11:18am

Dianthus offers up to $1B for China biotech’s autoimmune asset

Oct 16, 2025 10:57am

Evoq Therapeutics signs on with Sanofi in $500M partnership

Oct 16, 2025 10:25am

AstraZeneca pens fresh IBD collab with Immunai worth $85M

Oct 16, 2025 9:00am